Actionnariat et activité des initiés pour Enlivex Therapeutics Ltd. (ENLV): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.81 |
| Capitalisation | $14M |
| Bourse | NASDAQ |
| Pays | IL |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-03-18 | Hershkovitz Oren | |||
| 2023-11-16 | Hershkovitz Oren | 150,000 | $1.2M | |
| 2025-11-24 | Hershkovitz Oren | 60,000 | $320K | |
| 2026-03-18 | Shlosberger Shachar | |||
| 2021-03-07 | Shlosberger Shachar | 1,452 | $4K | |
| 2021-12-12 | Shlosberger Shachar | 1,452 | $9K | |
| 2024-03-30 | Shlosberger Shachar | 5,000 | $23K | |
| 2022-12-10 | Shlosberger Shachar | 1,452 | $15K | |
| 2025-11-24 | Shlosberger Shachar | 10,000 | $32K | |
| 2025-11-24 | Shlosberger Shachar | 7,500 | $40K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $6.9M | $3.5M | $9.7M | $3.9M | $5.7M | $11.2M | $49.9M | $813000 | $3.3M | $2.0M |
| Placements à Court Terme | $3.0M | 0 | $40000 | $8.1M | $30.0M | $72.9M | $299000 | $26.5M | $20.2M | $3.9M |
| Créances | $52000 | $28000 | $213000 | $2.4M | $1.2M | $1.1M | $647000 | $229000 | $1.3M | $235000 |
| Stocks | 0 | 0 | 0 | $1.5M | 0 | 0 | $1.2M | 0 | 0 | 0 |
| Actifs Courants | $10.5M | $3.6M | $10.3M | $16.4M | $38.1M | $86.4M | $52.3M | $33.8M | $26.0M | $1.74B |
| Immobilisations Corporelles | $71000 | $388 | $685000 | $1.1M | $2.1M | $8.2M | $14.9M | $2.6M | $1.2M | $938000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | $410000 | 0 | 0 | 0 | 0 | 0 | $582.5M |
| Actifs Totaux | $10.6M | $3.6M | $11.0M | $17.6M | $40.4M | $95.1M | $67.6M | $36.8M | $27.7M | $2.33B |
| Dettes Fournisseurs | $32000 | $19000 | $173000 | $316000 | $463000 | $878000 | $1.9M | $827000 | $811000 | $3.8M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $653000 | 0 | 0 | 0 |
| Passifs Courants | $1.9M | $460000 | $1.1M | $6.0M | $4.4M | $4.7M | $6.6M | $6.1M | $3.8M | $9.0M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.9M | $460000 | $1.3M | $6.3M | $4.9M | $10.1M | $10.8M | $6.7M | $4.1M | $392.1M |
| Réserves | -$39.8M | -$45.8M | -$16.3M | -$25.7M | -$37.5M | -$52.0M | -$83.0M | -$112.1M | -$127.1M | $1.11B |
| Capitaux Propres | $8.7M | $3.2M | $9.7M | $11.3M | $35.5M | $85.0M | $56.8M | $30.1M | $23.6M | $1.93B |
| Dette Totale | 0 | 0 | 0 | $123000 | $203000 | $6.0M | $4.8M | $1.0M | $534000 | $641000 |
| Dette Nette | -$9.9M | -$3.5M | -$9.8M | -$11.9M | -$35.5M | -$78.1M | -$45.4M | -$26.3M | -$23.1M | -$5.2M |
| Fonds de Roulement | $8.6M | $3.2M | $9.1M | $10.4M | $33.7M | $81.7M | $45.7M | $27.7M | $22.2M | $1.73B |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 193.24 |
Rentabilité
| Rentabilité des capitaux propres | 248.08% |
| Rentabilité du capital investi | -0.49% |
| Rentabilité des actifs | 53.10% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: CLGN · CVKD · GDTC · LSTA · MTVA · NCNA · NRSN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ENLV: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions